Amarin Corp Plcuk (AMRN) Current Deferred Revenue (2013 - 2024)

Amarin Corp Plcuk (AMRN) reported Current Deferred Revenue of $4.4 million for Q1 2024, down 70.14% year-over-year from $14.9 million in Q2 2023, and down 8.27% quarter-over-quarter from $4.8 million in Q4 2023.

Amarin Corp Plcuk (AMRN) Current Deferred Revenue (2013 - 2024) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 11 years of Current Deferred Revenue data on file, last reported at $4.4 million in Q1 2024.

  • Current Deferred Revenue for Q1 2024 came in at $4.4 million, down 70.14% year-over-year; the trailing twelve-month figure through Mar 2024 was $4.4 million (down 70.14% YoY), and the FY2023 annual result was $4.8 million, down 68.4% from the prior year.
  • Current Deferred Revenue declined to $4.4 million in Q1 2024 per AMRN's latest filing, from $4.8 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $21.8 million in Q1 2020 and troughed at $4.4 million in Q1 2024.
  • A 5-year average of $14.5 million and a median of $16.3 million in 2022 frame the typical range for Current Deferred Revenue.
  • The sharpest annual moves came in 2020 and 2024: Current Deferred Revenue rose 8.15% in 2020, then slumped 70.14% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $18.6 million in 2020, then slipped by 10.32% to $16.7 million in 2021, then retreated by 8.16% to $15.3 million in 2022, then tumbled by 68.4% to $4.8 million in 2023, then slipped by 8.27% to $4.4 million in 2024.
  • Business Quant data shows AMRN's Current Deferred Revenue at $4.4 million in Q1 2024, $4.8 million in Q4 2023, and $5.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 4.45 Mn
Dec 31, 2023 4.85 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 5.36 Mn
Mar 31, 2023 14.90 Mn
Dec 31, 2022 15.35 Mn
Sep 30, 2022 15.70 Mn
Jun 30, 2022 16.01 Mn
Mar 31, 2022 16.34 Mn
Dec 31, 2021 16.71 Mn
Sep 30, 2021 17.13 Mn
Jun 30, 2021 17.97 Mn
Mar 31, 2021 17.97 Mn
Dec 31, 2020 18.63 Mn
Sep 30, 2020 18.91 Mn
Jun 30, 2020 20.21 Mn
Mar 31, 2020 21.81 Mn
Dec 31, 2019 20.85 Mn
Sep 30, 2019 19.58 Mn
Jun 30, 2019 19.74 Mn